THANGARAJ IMMANUEL 4
4 · ACURA PHARMACEUTICALS, INC · Filed Jan 12, 2021
Insider Transaction Report
Form 4
THANGARAJ IMMANUEL
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-04+54,790→ 264,315 total - Exercise/Conversion
Restricted Stock Units (2017 Plan)
2021-01-04−54,790→ 0 total→ Common Stock (54,790 underlying)
Holdings
- 1,956,396(indirect: By Essex Woodlands Health Venture Fund V, L.P.)
Common Stock
Footnotes (7)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- [F3]Does not include Restricted Stock Units.
- [F4]1 - for - 1
- [F5]54,790 Restricted Stock Units were granted on the first business day of January 2020. 25% of Restricted Stock Units vested on March 31, 2020, 25% vested on June 30, 2020; 25% vested on September 30, 2020 and 25% vested on December 31, 2020. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
- [F6]N/A
- [F7]The reporting person is a managing director of the general partner of Essex Woodlands Health Ventures Fund V, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.